Orient Paper & Industries Files Compliance Certificate for Q4 FY26 Under SEBI Depositories Regulations

1 min read     Updated on 07 Apr 2026, 05:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Orient Paper & Industries Limited has submitted its compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming adherence to depositories regulations. The certificate was issued by registrar KFin Technologies Limited and submitted to BSE, NSE, NSDL, and CDSL on April 7, 2026. This routine regulatory filing demonstrates the company's commitment to maintaining transparency and compliance with securities market regulations governing dematerialization and rematerialization of securities.

powered bylight_fuzz_icon
37108949

*this image is generated using AI for illustrative purposes only.

Orient Paper & Industries Limited has fulfilled its regulatory obligations by submitting the mandatory compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission demonstrates the company's adherence to securities market regulations governing depositories and participants.

Regulatory Compliance Submission

The company filed the compliance certificate with stock exchanges on April 7, 2026, through its Company Secretary R.P. Dutta. The certificate was submitted to both major Indian stock exchanges where the company's shares are listed.

Exchange Details: Information
BSE Scrip Code: 502420
NSE Symbol: ORIENTPPR
Submission Date: April 7, 2026
Quarter Covered: March 31, 2026

Certificate Verification by Registrar

KFin Technologies Limited, serving as the Registrar & Share Transfer Agent for Orient Paper & Industries Limited, issued the compliance certificates on April 2, 2026. The certificates were signed by Sashidhar Mannava, Vice President of KFin Technologies Limited, confirming the company's compliance with regulatory requirements.

The certificates specifically confirm that details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, have been properly furnished to all stock exchanges where the company's shares are listed, as mandated under Regulation 74(5).

Depository Communications

Separate certificates were issued to both major depositories in India:

Depository: Details
NSDL: National Securities Depository Limited, Mumbai
CDSL: Central Depository Services (India) Limited, Mumbai
Certificate Reference: KFIN/OPIL/74(5) E/1
Issue Date: April 2, 2026

Company Information

Orient Paper & Industries Limited maintains its registered operations at Unit 8, Plot No 7, Bhoinagar, Bhubaneswar, Orissa 751012. The compliance submission reinforces the company's commitment to maintaining transparency and adhering to securities market regulations as prescribed by SEBI.

The quarterly compliance certificate represents a routine regulatory requirement that ensures proper tracking and reporting of securities transactions in dematerialized form, contributing to the overall integrity of India's securities market infrastructure.

Historical Stock Returns for Orient Paper & Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.22%+11.66%+5.82%-31.95%-19.50%-21.40%

Will Orient Paper & Industries face any operational challenges in maintaining compliance with upcoming SEBI regulatory changes in 2026?

How might the company's consistent regulatory compliance impact investor confidence and stock performance in the coming quarters?

What trends in dematerialization activity during Q1 2026 could indicate changes in retail vs institutional investor participation?

Orient Paper & Industries
View Company Insights
View All News
like15
dislike

Orient Paper & Industries Modifies Capital Expenditure Project for Tissue Machine Installation at Amlai Facility

1 min read     Updated on 28 Mar 2026, 07:25 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Orient Paper & Industries Limited has modified its capital expenditure project at the Amlai facility, replacing certain modernization initiatives with a new tissue machine installation. The revised project cost has increased from Rs. 125 crores to Rs. 213 crores, adding 23,400 TPA capacity to existing operations. The company has discontinued a separate Rs. 475 crores modernization project, having spent Rs. 239 crores, to align with its new strategic focus on advanced tissue manufacturing capabilities.

powered bylight_fuzz_icon
36208535

*this image is generated using AI for illustrative purposes only.

Orient Paper & Industries Limited has announced a strategic modification to its capital expenditure project at the Amlai manufacturing facility in Madhya Pradesh. The Board of Directors, in their meeting held on 27th March, 2026, approved significant changes to the original modernization plan, focusing on advanced tissue manufacturing capabilities.

Project Modification Details

The company has revised its capital expenditure strategy, replacing certain previously planned modernization initiatives with the installation of a new tissue machine incorporating advanced technology. This modification builds upon the original project disclosed on 5th August, 2025, representing a strategic shift in the company's manufacturing approach.

Parameter Original Plan Revised Plan
Project Scope Modernisation/de-bottlenecking Installation of new tissue machine
Investment Rs. 125 crores Rs. 213 crores (approx.)
Capacity Addition Not specified 23,400 TPA
Implementation Period Not specified Extended up to 2027-28

Capacity Enhancement and Investment

The modified project will add 23,400 TPA capacity to the existing 1,00,000 TPA at the Amlai facility. The full capacity is expected to be operational during FY 2029-30. The total project cost has been revised upward from Rs. 125 crores to approximately Rs. 213 crores, with financing planned through a mix of debt and internal accruals.

Strategic Rationale

The Board cited several factors driving this modification:

  • Evolving market dynamics in the paper industry
  • Changing demand patterns and increasing emphasis on product quality
  • Cost optimization requirements
  • Need for adoption of advanced and efficient manufacturing technologies

The company expects the revised project to deliver improved operational efficiency, enhanced production capacity, superior product quality, and better cost competitiveness, thereby strengthening its position in the tissue paper segment.

Impact on Existing Projects

In a related development, the Board decided to discontinue the modernization project that was approved on 15th March, 2023. This project had incurred and obligated Rs. 239 crores out of its sanctioned outlay of Rs. 475 crores. The decision aligns with the company's revised strategic direction focusing on tissue manufacturing capabilities.

Implementation Timeline

The modified project timeline extends the implementation period up to 2027-28, with the new tissue machine and related infrastructure expected to include expenses for maintenance, modernization, and energy cost optimization. The project aims to achieve product mix optimization while improving operational efficiency and productivity.

Historical Stock Returns for Orient Paper & Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.22%+11.66%+5.82%-31.95%-19.50%-21.40%

How will the increased investment from Rs. 125 crores to Rs. 213 crores impact Orient Paper's debt-to-equity ratio and financial leverage over the next two years?

What competitive advantages could the new tissue manufacturing technology provide against established players in India's tissue paper market?

Will the discontinuation of the Rs. 475 crore modernization project result in asset write-offs or impairment charges in upcoming quarterly results?

Orient Paper & Industries
View Company Insights
View All News
like19
dislike

More News on Orient Paper & Industries

1 Year Returns:-19.50%